104 related articles for article (PubMed ID: 1987736)
1. Teniposide (VM-26) in patients with advanced endometrial carcinoma. A phase II trial of the Gynecologic Oncology Group.
Muss HB; Bundy BN; Adcock L
Am J Clin Oncol; 1991 Feb; 14(1):36-7. PubMed ID: 1987736
[TBL] [Abstract][Full Text] [Related]
2. Teniposide (VM-26) in patients with non-squamous-cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
Muss HB; Bundy BN; Given FT; Stehman FB
Am J Clin Oncol; 1990 Apr; 13(2):117-8. PubMed ID: 2316480
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of teniposide in adenocarcinoma of the lung.
Sørensen JB; Bach F; Dombernowsky P; Hansen HH
Cancer Chemother Pharmacol; 1991; 27(6):487-9. PubMed ID: 2013120
[TBL] [Abstract][Full Text] [Related]
4. Teniposide in advanced breast cancer. A phase II trial in patients with no prior chemotherapy.
Nielsen D; Boas J; Engelholm SA; Hansen OP; Dombernowsky P
Ann Oncol; 1992 May; 3(5):377-8. PubMed ID: 1616891
[TBL] [Abstract][Full Text] [Related]
5. Teniposide in recurrent or advanced cervical carcinoma: a phase II trial in patients not previously treated with cytotoxic therapy.
Pfeiffer P; Cold S; Bertelsen K; Panduro J; Sandberg E; Rose C
Gynecol Oncol; 1990 May; 37(2):230-3. PubMed ID: 2344968
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of teniposide in advanced breast cancer.
Boas J; Rasmussen D; Hansen OP; Engelholm SA; Dombernowsky P
Cancer Chemother Pharmacol; 1990; 25(6):463-4. PubMed ID: 2311176
[TBL] [Abstract][Full Text] [Related]
7. Phase II evaluation of teniposide (VM-26) in metastatic breast carcinoma. A Southeastern Cancer Study Group trial.
Cox EB; Vogel CL; Carpenter JT; Raney M
Invest New Drugs; 1988 Apr; 6(1):37-9. PubMed ID: 3410666
[TBL] [Abstract][Full Text] [Related]
8. Teniposide (VM-26) in patients with advanced refractory ovarian cancer: a phase II study of the Netherlands Joint Study Group for Ovarian Cancer.
van der Burg ME; ten Bokkel Huinink WW; Vriesendorp R; van Oosterom AT; Neijt JP; Vermorken JB; van Putten WL; Kooiman A
Eur J Cancer Clin Oncol; 1987 Jul; 23(7):997-8. PubMed ID: 3666002
[TBL] [Abstract][Full Text] [Related]
9. Phase I study of oral teniposide (VM-26).
Smit EF; Ousterhuis BE; Berendsen HH; Sleijfer DT; Postmus PE
Semin Oncol; 1992 Apr; 19(2 Suppl 6):35-9. PubMed ID: 1329226
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate in advanced endometrial carcinoma. A phase II trial of the Gynecologic Oncology Group.
Muss HB; Blessing JA; Hatch KD; Soper JT; Webster KD; Kemp GM
Am J Clin Oncol; 1990 Feb; 13(1):61-3. PubMed ID: 2407104
[TBL] [Abstract][Full Text] [Related]
11. A phase II trial of teniposide (VM 26) in advanced non-Hodgkin's lymphoma, with emphasis on the treatment of elderly patients.
Tirelli U; Carbone A; Crivellari D; Volpe R; Franchin G; Veronesi A; Galligioni E; Trovò M; Tumolo S; Grigoletto E
Cancer; 1984 Aug; 54(3):393-6. PubMed ID: 6375853
[TBL] [Abstract][Full Text] [Related]
12. VM-26 in gastric cancer. A Southwest Oncology Group study.
Berenberg JL; Tangen C; Macdonald JS; Barlogie B; Laufman LR
Invest New Drugs; 1993 Nov; 11(4):333-4. PubMed ID: 8157475
[TBL] [Abstract][Full Text] [Related]
13. VM-26-vincristine-cisplatin combination chemotherapy in the treatment of primary advanced and recurrent endometrial carcinoma.
Sorbe B; Wolmesjö E; Frankendal B
Obstet Gynecol; 1989 Mar; 73(3 Pt 1):343-8. PubMed ID: 2915860
[TBL] [Abstract][Full Text] [Related]
14. Echinomycin in recurrent and metastatic endometrial carcinoma. A phase II trial of the Gynecologic Oncology Group.
Muss HB; Blessing JA; DuBeshter B
Am J Clin Oncol; 1993 Dec; 16(6):492-3. PubMed ID: 8256763
[TBL] [Abstract][Full Text] [Related]
15. High-dose teniposide for refractory malignancies: a phase I study.
de Vries EG; Mulder NH; Postmus PE; Vriesendorp R; Willemse PH; Sleijfer DT
Cancer Treat Rep; 1986 May; 70(5):595-8. PubMed ID: 3708608
[TBL] [Abstract][Full Text] [Related]
16. Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients.
Bork E; Hansen M; Dombernowsky P; Hansen SW; Pedersen AG; Hansen HH
J Clin Oncol; 1986 Apr; 4(4):524-7. PubMed ID: 3007684
[TBL] [Abstract][Full Text] [Related]
17. Teniposide (VM-26) as a single drug treatment for patients with extensive small cell lung carcinoma: a Phase II study of the Southwest Oncology Group.
Grozea PN; Crowley JJ; Canfield VA; Kingsbury L; Ross SW; Beltran GS; Laufman LR; Weiss GR; Livingston RB
Cancer; 1997 Sep; 80(6):1029-33. PubMed ID: 9305702
[TBL] [Abstract][Full Text] [Related]
18. Use of VM-26 as a single agent in the treatment of renal carcinoma.
Hire EA; Samson MK; Fraile RJ; Baker LH
Cancer Clin Trials; 1979; 2(4):293-5. PubMed ID: 394865
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
Thigpen JT; Blessing JA; Homesley H; Creasman WT; Sutton G
Gynecol Oncol; 1989 Apr; 33(1):68-70. PubMed ID: 2703169
[TBL] [Abstract][Full Text] [Related]
20. Teniposide in the treatment of non-small cell lung carcinoma.
Giaccone G; Donadio M; Ferrati P; Bonardi G; Ciuffreda L; Bagatella M; Calciati A
Cancer Treat Rep; 1987 Jan; 71(1):83-5. PubMed ID: 3024829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
